Japanese Foreign Ministry officially announced Putin's visit on December 15-16Russian Politics & Diplomacy December 08, 7:04
Putin to meet with head of Eurasian Economic CommissionRussian Politics & Diplomacy December 08, 6:22
Russian envoy says relations with NATO started deteriorating long before Ukrainian crisisWorld December 08, 4:55
Contact Group agrees to settle water cuts issue in Lugansk within 7 days ― OSCE envoyWorld December 08, 2:58
Glencore expects deal on purchasing stake in Rosneft to close in mid-DecemberBusiness & Economy December 08, 2:03
Italian Prime Minister Renzi officially resignsWorld December 08, 1:27
43 ceasefire violations reported in Syria in 24 hours ― Russian Defense MinistryWorld December 08, 1:16
One reconciliation agreement signed in Syria in 24 hours ― Russian Defense MinistryWorld December 08, 0:26
Lavrov confirms to Kerry Russia backs US proposal on Aleppo from December 2Russian Politics & Diplomacy December 07, 23:57
BEIJING, December 21. /TASS/. A Russian-Chinese center for the research of superconducting protons has been set up in the Chinese city of Hefei with the participation of the Joint Institute for Nuclear Research (headquartered in Dubna, outside Moscow), the Xinhua news agency reported on Monday.
"China and Russia have been cooperating on nuclear fusion research for more than 30 years, and partnership between the two countries in this sphere has been constantly growing," the news agency quoted the director of the Institute of Plasma Physics at the Chinese Academy of Sciences quoted its director, Kuang Guangli, as saying.
It said that within the next three years, center’s engineers plan to develop the first in China medical device for treating cancer and other grave diseases. In line with the signed agreements, in 2017 China will develop the main systems and parts for the new medical device, and in 2018 specialists from the two countries will make the first tests.
The use of chemotherapy and radiation therapy in treating cancer kills not only cancer cells but also big numbers of healthy cells.
The use of high-energy protons and heavy ions will make it possible to directly affect the tumor without damaging the healthy systems of the human body. Research on this is carried out in nowadays in many countries of the world.
The Joint Institute for Nuclear Research is one of the leaders in this direction of medical development.
The Joint Institute for Nuclear Research (JINR) is an international intergovernmental scientific research organisation established through the Convention signed on 26 March 1956 by eleven founding States and registered with the United Nations on 1 February 1957. It is situated in Dubna not far from Moscow.